Ultrasound–enhanced brain delivery of edaravone provides additive amelioration on disease progression in an ALS mouse model
Background: Although amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease and unfortunately incurable yet, incremental attention has been drawn to targeting the health of corticospinal motor neurons. Focused ultrasound combined with systemically circulating microbubbles (FU...
Main Authors: | Yuanyuan Shen, Ji Zhang, Yiluo Xu, Shuneng Sun, Kaili Chen, Siping Chen, Xifei Yang, Xin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Brain Stimulation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1935861X23017060 |
Similar Items
-
A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone
by: Erdi Şahin
Published: (2018-03-01) -
Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan
by: Hideki Houzen, et al.
Published: (2021-07-01) -
Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis
by: Benjamin Rix Brooks, et al.
Published: (2022-10-01) -
Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
by: Sun Joo Cha, et al.
Published: (2022-01-01) -
The Protective Effect of Edaravone on TDP-43 Plus Oxidative Stress-Induced Neurotoxicity in Neuronal Cells: Analysis of Its Neuroprotective Mechanisms Using RNA Sequencing
by: Aki Soejima-Kusunoki, et al.
Published: (2022-07-01)